|
DE286354C
(https=)
|
|
|
|
|
|
JPS6140270A
(ja)
|
1984-08-01 |
1986-02-26 |
Morishita Seiyaku Kk |
ピリダジノン誘導体
|
|
DE69131268T2
(de)
|
1990-09-21 |
1999-12-30 |
Rohm And Haas Co., Philadelphia |
Dihydropyridazinone und Pyridazinone als Fungizide
|
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
ES2293638T3
(es)
|
1994-03-25 |
2008-03-16 |
Isotechnika, Inc. |
Mejora de la eficacia de farmacos por deuteracion.
|
|
IL118631A
(en)
|
1995-06-27 |
2002-05-23 |
Tanabe Seiyaku Co |
History of pyridazinone and processes for their preparation
|
|
DE19629817A1
(de)
|
1996-07-24 |
1998-01-29 |
Hoechst Ag |
Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
|
|
NZ522882A
(en)
|
2000-06-05 |
2004-07-30 |
Altana Pharma Bv |
Pyridazinone compounds effective as beta-2-adrenoreceptor agonists as well as PDE4-inhibitors
|
|
WO2004022540A2
(en)
*
|
2002-09-06 |
2004-03-18 |
Fujisawa Pharmaceutical Co., Ltd. |
Pyridazinone and pyridone derivatives as adenosine antagonists
|
|
BRPI0407519A
(pt)
|
2003-03-07 |
2006-02-14 |
Kowa Co |
derivados de benzofurano
|
|
WO2006095666A1
(ja)
|
2005-03-07 |
2006-09-14 |
Kyorin Pharmaceutical Co., Ltd. |
ピラゾロピリジン－４－イルピリダジノン誘導体とその付加塩及びそれらを有効成分とするｐｄｅ阻害剤
|
|
WO2007044796A2
(en)
|
2005-10-11 |
2007-04-19 |
Nps Pharmaceuticals, Inc. |
Pyridazinone compounds as calcilytics
|
|
DE102005057924A1
(de)
|
2005-12-05 |
2007-06-06 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
HRP20130044T1
(hr)
|
2006-07-25 |
2013-02-28 |
Cephalon, Inc. |
Derivati piridizinona
|
|
MX2009008531A
(es)
|
2007-02-16 |
2009-08-26 |
Amgen Inc |
Cetonas de heterociclilo que contienen nitrogeno y su uso como inhibidores de c-met.
|
|
DE102007025717A1
(de)
|
2007-06-01 |
2008-12-11 |
Merck Patent Gmbh |
Arylether-pyridazinonderivate
|
|
DE102007025718A1
(de)
|
2007-06-01 |
2008-12-04 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
DE102007032507A1
(de)
|
2007-07-12 |
2009-04-02 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
GB0715087D0
(en)
*
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
DE102007038957A1
(de)
|
2007-08-17 |
2009-02-19 |
Merck Patent Gmbh |
6-Thioxo-pyridazinderivate
|
|
DE102008019907A1
(de)
|
2008-04-21 |
2009-10-22 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
WO2009142732A2
(en)
*
|
2008-05-20 |
2009-11-26 |
Cephalon, Inc. |
Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
|
AR081626A1
(es)
*
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
WO2012021707A2
(en)
|
2010-08-11 |
2012-02-16 |
The Regents Of The University Of California |
Premature-termination-codons readthrough compounds
|
|
US8975260B2
(en)
|
2010-09-01 |
2015-03-10 |
Genetech, Inc |
Pyridazinones, method of making, and method of use thereof
|
|
US8759380B2
(en)
|
2011-04-22 |
2014-06-24 |
Cytokinetics, Inc. |
Certain heterocycles, compositions thereof, and methods for their use
|
|
WO2013057101A1
(de)
|
2011-10-17 |
2013-04-25 |
Bayer Intellectual Property Gmbh |
Substituierte oxadiazolylpyridinone und - pyridazinone als hif - hemmer
|
|
CN103570730A
(zh)
|
2012-08-01 |
2014-02-12 |
中国科学院上海药物研究所 |
具有桥环结构的稠环哒嗪酮类化合物及其制备方法和用途
|
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
US9566310B2
(en)
*
|
2012-09-10 |
2017-02-14 |
Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno |
Methods of treating muscular dystrophy
|
|
US9216180B2
(en)
|
2012-10-02 |
2015-12-22 |
New York University |
Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated RNA decay
|
|
JP2016507496A
(ja)
|
2012-12-21 |
2016-03-10 |
ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． |
ブロモドメイン阻害剤としての新規複素環式化合物
|
|
HUE032863T2
(en)
|
2013-02-07 |
2017-11-28 |
Merck Patent Gmbh |
Piridazinonamid derivatives
|
|
EP2968323A4
(en)
|
2013-03-13 |
2016-12-14 |
Flatley Discovery Lab |
PYRIDAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
|
|
WO2014189634A1
(en)
*
|
2013-04-19 |
2014-11-27 |
University Of Iowa Research Foundation |
Angiotensins in muscular dystrophy
|
|
WO2019051125A1
(en)
*
|
2017-09-06 |
2019-03-14 |
Translational Drug Development, Llc |
AMINOBENZIMIDAZOLE DERIVATIVES, TREATMENTS AND METHODS FOR INHIBITING HISTONE DEACETYLASE
|
|
CA2987980A1
(en)
*
|
2015-06-05 |
2016-12-08 |
Ptc Therapeutics, Inc. |
Use of an aminoglycoside for nonsense mutation suppression and the treatment of disease
|
|
EP3307891B8
(en)
*
|
2015-06-10 |
2019-11-13 |
Association Institut de Myologie |
Combined therapy for duchenne muscular dystrophy
|
|
CN106467495A
(zh)
|
2015-08-19 |
2017-03-01 |
中国科学院上海药物研究所 |
哒嗪酮类化合物、其制备方法、药物组合物及用途
|
|
WO2017046117A1
(en)
|
2015-09-15 |
2017-03-23 |
Abbvie Inc. |
Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use
|
|
WO2018081378A1
(en)
*
|
2016-10-26 |
2018-05-03 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods for modulating cftr
|
|
CA3041675A1
(en)
*
|
2016-10-26 |
2018-05-03 |
Proteostasis Therapeutics, Inc. |
N-phenyl-2-(3-phenyl-6-oxo-1,6-dihydropyridazin-1-yl)acetamide derivatives for treating cystic fibrosis
|
|
WO2018081381A1
(en)
|
2016-10-26 |
2018-05-03 |
Proteostasis Therapeutics, Inc |
Pyridazine derivatives, compositions and methods for modulating cftr
|
|
CN110573161A
(zh)
|
2017-03-28 |
2019-12-13 |
勃林格殷格翰国际有限公司 |
用于治疗肌营养不良的方法的尼达尼布
|
|
TWI829634B
(zh)
|
2017-04-06 |
2024-01-21 |
美商富曼西公司 |
殺真菌之噁二唑
|
|
US20180303821A1
(en)
|
2017-04-24 |
2018-10-25 |
BraneQuest, Inc. |
Membrane active molecules
|
|
BE1025518B1
(fr)
|
2017-08-30 |
2019-04-03 |
E2 Drives Sa |
Groupe motopropulseur
|
|
US11065243B2
(en)
|
2017-10-27 |
2021-07-20 |
Sonic Master Limited |
Inhibitors of DUX4 induction for regulation of muscle function
|
|
JP7623680B2
(ja)
|
2018-05-17 |
2025-01-29 |
ボルト スレッズ インコーポレイテッド |
組換えタンパク質の分泌を改善するためのｓｅｃ改変株
|
|
EP4685140A1
(en)
|
2018-06-04 |
2026-01-28 |
Ohio State Innovation Foundation |
Eaat2 activators and methods of using thereof
|
|
EP3828174A4
(en)
|
2018-07-19 |
2022-08-17 |
Sumitomo Pharma Co., Ltd. |
PYRIDAZINONE DERIVATIVE
|
|
CN108947912B
(zh)
|
2018-07-31 |
2021-10-01 |
中国人民解放军总医院 |
一种靶向Neddylation通路的抗肿瘤化合物
|
|
WO2020097258A1
(en)
|
2018-11-06 |
2020-05-14 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
|
EP3877052B1
(en)
|
2018-11-06 |
2023-08-16 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
|
ES2958954T3
(es)
*
|
2018-11-06 |
2024-02-16 |
Edgewise Therapeutics Inc |
Compuestos de piridazinona y usos de los mismos
|
|
EP4149620B1
(en)
|
2020-05-13 |
2024-10-23 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds for the treatment of neuromuscular diseases
|
|
JP7758687B2
(ja)
|
2020-05-13 |
2025-10-22 |
エッジワイズ セラピューティクス， インコーポレイテッド |
神経筋疾患の処置のためのピリダジノン化合物
|
|
WO2021231630A1
(en)
|
2020-05-13 |
2021-11-18 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
|
WO2021231546A1
(en)
|
2020-05-13 |
2021-11-18 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
|
WO2021231615A1
(en)
|
2020-05-13 |
2021-11-18 |
Edgewise Therapeutics, Inc. |
Substituted pyridazinone for use in the treatment of neuromuscular diseases
|
|
JP7694135B2
(ja)
|
2021-05-11 |
2025-06-18 |
株式会社大林組 |
接続構造及び接続方法
|
|
EP4433473A1
(en)
|
2021-11-17 |
2024-09-25 |
Edgewise Therapeutics, Inc. |
Pyridazinone compounds and uses thereof
|
|
EP4522599A1
(en)
|
2022-05-11 |
2025-03-19 |
Edgewise Therapeutics, Inc. |
Methods of manufacturing pyridazinone compounds
|
|
JP2025530218A
(ja)
|
2022-09-09 |
2025-09-11 |
エッジワイズ セラピューティクス， インコーポレイテッド |
神経筋の状態の処置のためのピリダジノン組成物
|